http://rdf.ncbi.nlm.nih.gov/pubchem/reference/7279309

Outgoing Links

Predicate Object
contentType Clinical Trial, Phase II|Journal Article|Multicenter Study|Randomized Controlled Trial|Research Support, Non-U.S. Gov't
endingPage 2554
issn 1522-9645
0195-668X
issueIdentifier 20
pageRange 2541-2554
publicationName European Heart Journal
startingPage 2541
bibliographicCitation Steg PG, Mehta SR, Jukema JW, Lip GY, Gibson CM, Kovar F, Kala P, Garcia-Hernandez A, Renfurm RW, Granger CB; RUBY-1 Investigators. RUBY-1: a randomized, double-blind, placebo-controlled trial of the safety and tolerability of the novel oral factor Xa inhibitor darexaban (YM150) following acute coronary syndrome. Eur Heart J. 2011 Oct;32(20):2541–54. PMID: 21878434; PMCID: PMC3295208.
creator http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_af3e08121c2a8fdc5d9c4525aa765925
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_9c6d7dc09630b574003d8802cdfbf49e
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_7a32e1e0e71e5d6adacaaff8db3f97f2
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_a69a860a88c6c56ca080ea36bf0aeec4
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_e110d15785273d057442e11ac8360344
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_fee0f021427c869429050e84de139aca
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_a00c3f0888289f5839a91fd99b1c77e4
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_553d09005f6642abb25988e8d6c3dabb
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_c43848a698f5fbe84e56171fdf0a48e8
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_a59f85943559e5a09c1e3eec644aceb7
date 2011-08-30-04:00^^<http://www.w3.org/2001/XMLSchema#date>
identifier https://doi.org/10.1093/eurheartj/ehr334
https://pubmed.ncbi.nlm.nih.gov/21878434
https://pubmed.ncbi.nlm.nih.gov/PMC3295208
isPartOf http://rdf.ncbi.nlm.nih.gov/pubchem/journal/3586
https://portal.issn.org/resource/ISSN/0195-668X
https://portal.issn.org/resource/ISSN/1522-9645
language English
source https://www.crossref.org/
https://pubmed.ncbi.nlm.nih.gov/
title RUBY-1: a randomized, double-blind, placebo-controlled trial of the safety and tolerability of the novel oral factor Xa inhibitor darexaban (YM150) following acute coronary syndrome
discusses http://id.nlm.nih.gov/mesh/M0002069
http://id.nlm.nih.gov/mesh/M0002327
http://id.nlm.nih.gov/mesh/M0587609
http://id.nlm.nih.gov/mesh/M0570561
hasPrimarySubjectTerm http://id.nlm.nih.gov/mesh/D054058Q000188
http://id.nlm.nih.gov/mesh/D065427
hasSubjectTerm http://id.nlm.nih.gov/mesh/D004311
http://id.nlm.nih.gov/mesh/D001549Q000009
http://id.nlm.nih.gov/mesh/D009203Q000209
http://id.nlm.nih.gov/mesh/D001381Q000008
http://id.nlm.nih.gov/mesh/D006470Q000139
http://id.nlm.nih.gov/mesh/D001549Q000008
http://id.nlm.nih.gov/mesh/D017202Q000517
http://id.nlm.nih.gov/mesh/D055502
http://id.nlm.nih.gov/mesh/D006801
http://id.nlm.nih.gov/mesh/D008297
http://id.nlm.nih.gov/mesh/D001381Q000009
http://id.nlm.nih.gov/mesh/D020521Q000209
http://id.nlm.nih.gov/mesh/D013923Q000209
http://id.nlm.nih.gov/mesh/D016896
http://id.nlm.nih.gov/mesh/D008875
http://id.nlm.nih.gov/mesh/D005260
http://id.nlm.nih.gov/mesh/D000284
http://id.nlm.nih.gov/mesh/D053208
http://id.nlm.nih.gov/mesh/D012307
http://id.nlm.nih.gov/mesh/D004305
discussesAsDerivedByTextMining http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8564
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID9410
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID11167
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7969
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID10602
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID11015
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8198
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID9912771

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127638306
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128926582
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID245521420
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID248153327
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128447465
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127719861
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID245255101
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID243716447
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129740296
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID244491953
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127968075
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127684899
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127648365
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127563695
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129046631

Total number of triples: 79.